June is upon us. The year is nearly halfway gone, and since the turn of the calendar, there have been a lot of learnings on where the home health industry currently sits — and where it may be headed.
But everything will be reset in the next month when the Centers for Medicare & Medicaid Services (CMS) drops its CY2024 proposed payment rule.
“I think, in general, the broad consensus view is that CMS will pursue completing out the second phase of the behavioral adjustments,” Scott Fidel, managing director at Stephens Inc., told me last week. “There is also still substantial uncertainty around the clawback piece of this, and whether CMS will pursue that, and to what degree. That clearly could create more volatility.”
“I don’t think there was much surprise at all to see Amedisys announce that they are merging with another company,” Fidel said. “I think there has been a lot of focus and speculation around whether Amedisys and other large standalone home health and hospice operators would be looking to merge, just given the recent trends that we’ve already seen.”
Stephens Investment Banking Expands European and UK Specialty Finance with Two New Senior Bankers
Stephens Investment Banking Expands Technology Capabilities with New Sector Banker